Opko Health, Inc. Closes Offering of $175 Million of 3.00% Convertible Senior Notes Due 2033
Published: Jan 31, 2013
MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE: OPK) today announced the closing of its offering of $175.0 million aggregate principal amount of 3.00% convertible senior notes due 2033 (the “Notes”) in a private offering. OPKO intends to use the approximately $170.3 million of net proceeds from this offering for general corporate purposes, including research and development expenses, acceleration of clinical trials, acquisitions of new technologies or businesses, and other business opportunities.